The medical device supplier is charged with fraudulently submitting millions of dollars in billing for devices that were not necessary, covered, or agreed to by patients.
Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.
Using data from 2 million claims across 32 states, the study found that the prevalence of these surgeries increased, driven by shoulder joint replacements.
While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.
After regional public health collaboratives formed in September, New York could be the first state to formally shift policies away from deferring to federal guidelines.
What are the latest developments in climate change, and how does it continue to impact front-line workers such as ocean workers and construction workers?
With the Trump Administration’s new tariff on prescription medications, how are drug manufacturers reacting, and how might the workers’ compensation system be impacted?
Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.
CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.
In workers’ comp, comorbidities like hypertension require a focus on drug-drug and drug-disease interactions to ensure effective and safe treatment plans.
